Article,
Development of a Comprehensive Model for Cancer Symptom Care for Women With Ovarian or Endometrial Cancer
Contributors
Christiansen, Mille Guldager
0000-0002-1507-1130
[1]
[2]
Jarden, Mary
0000-0003-3040-8384
[1]
[3]
[4]
Colomer-Lahiguera, Sara
0000-0003-2390-5198
[5]
[6]
Eicher, Manuela R E
0000-0002-7691-0719
[5]
[6]
Bryant-Lukosius, Denise E
0000-0002-8269-7977
[7]
Mirza, Mansoor Raza
0000-0002-8085-1010
[1]
[2]
Pappot, Helle
0000-0002-3570-5372
[1]
[2]
[4]
Piil, Karin
0000-0001-7972-4674
[1]
[2]
[8]
Affiliations
- [1] Author Affiliations: Centre for Cancer and Organ Diseases (M. Jarden, K. Piil, M. G. Christiansen, H. Pappot, and M. R. Mirza)
- [2] Department of Oncology, Copenhagen University Hospital, Denmark (K. Piil, M. G. Christiansen, H. Pappot, and M. R. Mirza)
- [3] Department of Hematology, Copenhagen University Hospital, Denmark (M. Jarden)
- [4] University of Copenhagen [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
- [5] University Hospital of Lausanne [NORA names: Switzerland; Europe, Non-EU; OECD];
(... more)
Abstract
Background: Women with ovarian or endometrial cancer experience multiple symptoms during chemotherapy. Specialized cancer nurses possess specific knowledge and competencies to effectively monitor and manage treatment-related toxicities and provide self-management support. Objective: To describe the conception and development of a comprehensive cancer symptom model of care in an oncological setting for women diagnosed with ovarian or endometrial cancer. Methods: The participatory evidence-based, patient-focused process for guiding the development, implementation, and evaluation of advanced practice nursing roles—the participatory, evidence-based, patient-centered process for advanced practice (PEPPA) framework directed the process. The first 6 steps of this 9-step framework were utilized to incorporate research evidence, engage, and obtain the input of key stakeholders. Results: Stakeholders (n = 27) contributed with specific knowledge, perspectives, and feedback to the entire development process, and several needs were identified. Following structured discussions, a new model of cancer symptom care with elements such as symptom management, electronic patient-reported outcomes, and an expanded nursing role in the form of nurse-led consultations was developed. Conclusions: We effectively utilized the PEPPA framework to design a new cancer symptom model of care, that was agreed upon by key stakeholders. Implications for Practice: This stakeholder-engaged, and evidence-driven process could be used as a template for others wanting to develop a population-specific model of care to improve cancer symptom management. What is Foundational: With the expansion of the cancer nursing role, the new model has the potential to improve the quality of cancer care and health outcomes related to symptom management.
